Central Pacific Bank - Trust Division’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.2M Buy
16,537
+173
+1% +$40.3K 0.43% 47
2026
Q1
$4M Buy
16,364
+423
+3% +$98.5K 0.51% 35
2025
Q4
$3.3M Sell
15,941
-1,074
-6% -$212K 0.4% 54
2025
Q3
$3.15M Sell
17,015
-342
-2% -$58.6K 0.38% 62
2025
Q2
$2.65M Buy
17,357
+87
+0.5% +$13.4K 0.34% 77
2025
Q1
$2.86M Sell
17,270
-1,328
-7% -$208K 0.4% 61
2024
Q4
$2.69M Sell
18,598
-358
-2% -$55.5K 0.35% 58
2024
Q3
$3.07M Buy
18,956
+32
+0.2% +$5.1K 0.39% 58
2024
Q2
$2.77M Sell
18,924
-634
-3% -$94.3K 0.33% 63
2024
Q1
$3.09M Buy
+19,558
New +$3.11M 0.38% 52

Other funds holding JNJ

Central Pacific Bank - Trust Division's JNJ Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Johnson & Johnson (JNJ) stake by 1.1% in Q2 2026, buying an estimated $40.3K and bringing the position to 16,537 shares worth $4.2M. The position accounts for 0.43% of the portfolio, ranked #47.

Central Pacific Bank - Trust Division first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. 1,808 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Central Pacific Bank - Trust Division held 16,537 shares of Johnson & Johnson worth $4.2M as of Q2 2026.
  • Central Pacific Bank - Trust Division bought 173 Johnson & Johnson shares in Q2 2026, an estimated $40.3K.
  • Johnson & Johnson made up 0.43% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #47 holding.
  • Central Pacific Bank - Trust Division first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • 1,808 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.